Coherus Announces Resubmission of Biologics License Application (BLA) Supplement for Udenyca ® OnBody™

REDWOOD CITY, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) today announced the Company has resubmitted the Biologics License Application (BLA) Supplement for UDENYCA® ONBODY™, the company ' s...

Source: Drugs.com - New Drug Applications - October 5, 2023 Category: Drugs & Pharmacology Source Type: news